The Alpha-1 Foundation is dedicated to providing the leadership and resources that will result in increased research, improved health, worldwide detection and a cure for Alpha-1 Antitrypsin Deficiency (AAT Deficiency or Alpha-1). Alpha-1 is a genetic disorder that can cause liver and lung disease in children and adults. The Foundation has realized continuous growth since its inception in 1995 and has developed a solid infrastructure to promote research and the development of new therapies for improving the quality of life for those diagnosed with AAT Deficiency. The Foundation has fostered collaborations with investigators throughout the United States and in Europe.
Address: 2937 Southwest 27th Avenue Suite 302
Miami, FL 33133